New hope for men with returning prostate cancer: 5-Day radiation blast

NCT ID NCT05746806

First seen Jan 03, 2026 · Last updated May 15, 2026 · Updated 21 times

Summary

This study tests a new approach for men whose prostate cancer comes back after surgery to remove the prostate. It combines a short course of hormone therapy (6 months) with highly focused radiation given in just 5 sessions. The goal is to see if this treatment can control the cancer and delay further progression, while keeping side effects manageable. About 36 men will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECURRENT PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Inselgruppe AG, Inselspital

    Bern, 3010, Switzerland

  • Istituto Oncologico della Svizzera Italiana-Ente Ospedaliero Cantonale (IOSI-EOC)

    Bellinzona, 6500, Switzerland

  • Kantonsspital Winterthur, Klinik für Radio-Onkologie

    Winterthur, 8401, Switzerland

  • Universitätsspital Basel

    Basel, 4031, Switzerland

  • Universitätsspital Zürich, Klinik für Radio-Onkologie

    Zurich, 8091, Switzerland

Conditions

Explore the condition pages connected to this study.